The decision in Europe follows an approval granted by the US Food and Drug Administration (FDA) in March this year.

In a new era of Alzheimer’s disease research, the emergence of blockbuster therapies like Eli Lilly’s Kisunla (donanemab) and ...

Allarity maintains a cash balance of $18.5 million, sufficient to advance and accelerate stenoparib's clinical development ...

AbbVie's $10.1 billion takeover of ImmunoGen has been rewarded with EU approval for Elahere, the first drug specifically ...

An Osaka Metropolitan University-led team evaluated the effects of SGLT2 inhibitors in protecting the kidneys, showing that ...

We were all shocked when word slipped out that Jumana Murad was a married lady! The whole deal was very quick to come to pass ...

Needham analyst Ami Fadia downgraded Biogen (BIIB) to Hold from Buy.Don't Miss our Black Friday Offers:Discover the latest stocks recommended ...

Biogen (BIIB – Research Report) received a Hold rating and price target from Needham analyst Ami Fadia today. The company’s shares closed last Friday at $159.99. Don't Miss our Black Friday Offers: ...

OPUVIZ is one of the first wave aflibercept biosimilars in Europe OPUVIZ is the second European Commission (EC)-approved ophthalmology biosimilar under Samsung Bioepis and Biogen's partnership EC ...

Biden Allows Ukraine to Strike Russia With Long-Range U.S. Missiles President Biden for the first time authorized the use of a system known as ATACMS to help defend Ukraine’s forces in the Kursk ...

Veteran broadcaster Alan Jones has been charged with historical indecent assault and sexual touching offences spanning two decades.

Why the iPhone SE 4 Could Be One of Apple's Most Important Products of 2025 ...